VOYA Investment Management
XERS icon

VOYA Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

VOYA Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.63M Buy
625,310
+166,981
+36% +$1.11M ﹤0.01% 960
2025
Q4 		$3.6M Buy
458,329
+58,250
+15% +$458K ﹤0.01% 995
2025
Q3 		$3.26M Buy
400,079
+358,689
+867% +$2.38M ﹤0.01% 1042
2025
Q2 		$193K Buy
41,390
+1,595
+4% +$7.31K ﹤0.01% 2338
2025
Q1 		$218K Sell
39,795
-4,958
-11% -$20K ﹤0.01% 2264
2024
Q4 		$152K Sell
44,753
-3,613
-7% -$11.6K ﹤0.01% 2473
2024
Q3 		$138K Sell
48,366
-366
-0.8% -$940 ﹤0.01% 2586
2024
Q2 		$110K Buy
48,732
+4,633
+11% +$9.34K ﹤0.01% 2640
2024
Q1 		$97.5K Sell
44,099
-11,778
-21% -$30.5K ﹤0.01% 2624
2023
Q4 		$131K Buy
55,877
+2,031
+4% +$3.75K ﹤0.01% 2691
2023
Q3 		$100K Hold
53,846
– – ﹤0.01% 2732
2023
Q2 		$141K Buy
53,846
+2,415
+5% +$6.15K ﹤0.01% 2698
2023
Q1 		$83.8K Hold
51,431
– – ﹤0.01% 2727
2022
Q4 		$68.4K Hold
51,431
– – ﹤0.01% 2815
2022
Q3 		$80.2K Hold
51,431
– – ﹤0.01% 2830
2022
Q2 		$79K Buy
+51,431
New +$109K ﹤0.01% 2678
2021
Q2 		– Sell
-20,975
Closed -$95K – 2910
2021
Q1 		$95K Hold
20,975
– – ﹤0.01% 2678
2020
Q4 		$103K Buy
20,975
+5,996
+40% +$30K ﹤0.01% 2555
2020
Q3 		$89K Buy
14,979
+1,776
+13% +$7.1K ﹤0.01% 2363
2020
Q2 		$35K Sell
13,203
-193
-1% -$672 ﹤0.01% 2480
2020
Q1 		$26K Hold
13,396
– – ﹤0.01% 2570
2019
Q4 		$94K Buy
13,396
+3,382
+34% +$27.9K ﹤0.01% 2562
2019
Q3 		$98K Hold
10,014
– – ﹤0.01% 2419
2019
Q2 		$115K Buy
+10,014
New +$105K ﹤0.01% 2434

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's XERS Position: Q1 2026 in Review

VOYA Investment Management increased its Xeris Biopharma Holdings (XERS) stake by 36% in Q1 2026, buying an estimated $1.11M and bringing the position to 625,310 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #960.

VOYA Investment Management first reported a position in XERS in Q2 2019 and has held it in 24 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • VOYA Investment Management held 625,310 shares of Xeris Biopharma Holdings worth $3.63M as of Q1 2026.
  • VOYA Investment Management bought 166,981 Xeris Biopharma Holdings shares in Q1 2026, an estimated $1.11M.
  • Xeris Biopharma Holdings made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #960 holding.
  • VOYA Investment Management first reported a position in Xeris Biopharma Holdings in Q2 2019 and has held it in 24 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.